New Telehealth Platform Offers Medically Supervised Access to Compounded GLP-1 Medications

Direct Meds connects patients with licensed physicians to evaluate suitability for weight management treatments

Apr. 19, 2026 at 3:39am

Got story updates? Submit your updates here. ›

An extreme close-up, translucent X-ray photograph showing the intricate internal structures of the human digestive system glowing with a faint blue-green light, conceptually representing the biological mechanisms behind weight management.A detailed X-ray view of the human digestive system reveals the complex hormonal pathways that GLP-1 medications aim to influence for weight management.NYC Today

Direct Meds, a U.S.-based telehealth platform, provides patients access to licensed physicians who can evaluate their suitability for compounded GLP-1 weight management medications. The platform has served over 180,000 customers and holds LegitScript certification, verifying compliance with applicable laws and regulations. Patients complete an online medical intake, then are connected with board-certified physicians who review their health history and determine if a compounded GLP-1 medication is clinically appropriate. If prescribed, the medications are prepared by U.S.-based compounding pharmacies and shipped directly to the patient's door.

Why it matters

GLP-1 medications represent a significant shift in medically supervised weight management, as they work directly on the hormonal signals that control hunger and fullness. Large clinical trials of FDA-approved GLP-1 active ingredients have shown participants lost a significant amount of weight when they also followed a diet and exercised. Direct Meds provides a streamlined, telehealth-based pathway for patients to access these treatments under medical supervision.

The details

Direct Meds is not a pharmacy or drug manufacturer, but rather a platform that connects patients with licensed physicians who can evaluate their suitability for compounded GLP-1 medications. The active ingredients used, semaglutide and tirzepatide, are the same as those found in several FDA-approved products, but the compounded formulations themselves have not been reviewed by the FDA. Direct Meds handles the intake process, telehealth consultation, and logistics, while the prescribing and dispensing are done by independent licensed physicians and pharmacies.

  • Direct Meds was founded in 2022 and has served over 180,000 customers to date.
  • The platform received LegitScript certification in 2024, verifying its compliance with applicable laws and regulations.

The players

Direct Meds

A U.S.-based telehealth platform that provides patients access to licensed physicians who can evaluate their suitability for compounded GLP-1 weight management medications.

LegitScript

A recognized standard for legitimate online healthcare platforms that verifies compliance with applicable laws and regulations.

Got photos? Submit your photos here. ›

What’s next

Patients interested in exploring GLP-1 medication options can visit the Direct Meds website to learn more and initiate the online medical intake process.

The takeaway

Direct Meds provides a convenient, telehealth-based pathway for patients to access compounded GLP-1 medications under the supervision of licensed physicians, potentially offering a new tool in the ongoing battle against weight management challenges.